London, United Kingdom - February 12, 2014, London, United Kingdom - Hikma Pharmaceuticals announcd several changes to its board composition, effective the Annual General Meeting on May 15, 2014.
Article continues below
Samih Darwazah, non-executive Chairman, is to retire from the Board and become honorary Life President.
Mr. Samih Darwazah founded Hikma Pharmaceuticals in Jordan in 1977 and listed Hikma on the London Stock Exchange in 2005. He was Chairman and Chief Executive of Hikma until 2007, when he relinquished his executive responsibilities. In the same year, he won Ernst and Young's Middle East Entrepreneur of the Year Award.
A Fulbright scholar, Mr. Samih Darwazah holds a Masters Degree in Industrial Pharmacy from the St. Louis College of Pharmacy, Missouri, and an honorary Doctor of Science degree. He obtained his BSc Degree in Pharmacy from the American University of Beirut (AUB). AUB awarded Samih the Distinguished Alumnus Award for his accomplishments in the international healthcare industry.
Mr. Samih Darwazah served as Minister of Energy and Mineral Resources in Jordan between 1995 and 1996. He also founded the Jordan Exporters' Association and served as a member of the Senate of the Hashemite Kingdom of Jordan. Samih was employed at Eli Lilly from 1964 to 1976.
Said Darwazah, Chief Executive, is to be appointed Chairman & Chief Executive.
Mr. Said Darwazah was appointed Chief Executive Officer in July 2007. He was Chairman and Chief Executive of the Hikma's group holding company from 1994 to 2003 and Minister of Health for the Hashemite Kingdom of Jordan from 2003 to 2006.
During his thirty two years at Hikma, Mr. Said Darwazah has undertaken several executive roles. He has a degree in industrial engineering from Purdue University and an MBA from INSEAD.
Sir David Rowe-Ham, Senior Independent Director, is to retire from the Board.
Sir David is a former Lord Mayor of London, and has held many senior positions in UK financial institutions including serving as Chairman of Brewin Dolphin Holdings PLC and Arden Partners PLC. He is a past President of The Crown Agents Foundation and a former regional director of Lloyds Bank plc.
Robert Pickering, non-executive director, is to be appointed Senior Independent Director and Chairman of the Nomination Committee. Mr. Pickering will become a member of the Remuneration Committee and cease to be a member of the Compliance, Responsibility and Ethics Committee (CREC). ■